Study Investigating Intravesical HDAC Inhibition to Improve Response to Immuno-Oncology Agents
Clinical trial NCT06963346 · RECRUITING
Trial details
- NCT number
- NCT06963346
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-24
- Primary completion
- 2028-04-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.